The weekly litigation news digest is live. Subscribe now

Bioregen Biomedical Changzhou competitive analysis

Loading summary...

Explore Bioregen Biomedical Changzhou's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 4, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jan 3, 2018Injectable In-Situ Crosslinked Hydrogel And The Preparation Method And Use Thereof1

Latest PTAB cases involving Bioregen Biomedical Changzhou

Discover the latest PTAB cases involving Bioregen Biomedical Changzhou, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bioregen Biomedical Changzhou with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOREGEN BIOMEDICAL CHANGZHOU - 1 - -
CROMA PHARMA GESELLSCHAFT2 - - -